Page 50 - Michael Erman News Today

(Reuters) -Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID...

(Reuters) -Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID...

By Michael Erman NEW YORK (Reuters) - Pfizer Inc and BioNTech SE said on Saturday that a booster dose of updated versions of their COVID-19 vaccine, m...

By Michael Erman NEW YORK (Reuters) - COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the ori...

(Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Thursday to decide on the use of Moderna Inc's COVID-...

(Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Thursday to decide on the use of Moderna Inc's COVID-...

(Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday unanimously voted...

(Reuters) -Moderna Inc said on Wednesday that an updated version of its COVID-19 vaccine designed to target the Omicron variant also generated a strong immune response against the fast-spreading Omicron

FDA advisers overwhelmingly back Moderna COVID vaccine for ages 6-17 | 2022-06-15 11:00:00

(Reuters) -Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agenc...